Global Oncology Antibody Drug Conjugates Market

2022-04-28 11:58:47 UTC | Healthcare & Pharmaceuticals
Global Oncology Antibody Drug Conjugates Market

According to a new market research report published by Global Market Estimates, the Global Oncology Antibody Drug Conjugates Market is projected to grow from USD 9.87 billion in 2022 to USD 22.48 billion at a CAGR value of 12.4% from 2022 to 2027.

Browse 155 Market Data Tables and 133 Figures spread through 156 Pages and in-depth TOC on “Global oncology antibody drug conjugates Market - Forecast to 2027’’

Pfizer Inc., Astellas Pharma Inc., Gilead Sciences, Inc., GlaxoSmithKline, F. Hoffmann-La Roche AG, Daiichi Sankyo, AstraZeneca, Sanofi, AbbVie, Merck & Co., Byondis, RemeGen, ImmunoGen, Seagen, Rakuten Medical, BioAtla, Bicycle Therapeutics, ADC Therapeutics, Genmab, Helix BioPharma, CytomX, and Innate Pharma, among others, are the some of the key players in the oncology antibody drug conjugates market

Indication Size Outlook (Revenue, USD Billion, 2022-2027)

·         Breast Cancer

·         Ovarian Cancer

·         Cervical Cancer

·         NSCLC

·         Colorectal Cancer

·         Pancreatic Cancer

·         Hodgkin Lymphoma

·         Leukemia

·         Gastric Cancer

·         Others

Regional Outlook (Revenue, USD Billion, 2022-2027)

North America                                                                                 


Asia Pacific

Central & South America

Middle East & Africa


Contact: Yash Jain

Email address:

Phone Number: +1 6026667238